# GMP Companies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gmp-companies

- Industry: Biotechnology
- Headquarters: Fort Lauderdale, US
- Website: www.lifesynccorp.com
- Total disclosed funding: $17M
- Latest round: Series A (Jan 8, 2007)
- Investors on record: 4

## About

GMP Companies, Inc. operates in the healthcare sector, focusing on the design and manufacturing of medical cables and connections that enhance patient monitoring solutions for healthcare providers.Founded in Fort Lauderdale, US, GMP Companies, Inc. specializes in producing medical cables and neuromonitoring connections. The company raised USD 17.2 mn in a Series A funding round on January 8, 2007, with investors including Janus Henderson Investors and BVM Capital. Details about the founder are not available.LifeSync specializes in the design, manufacturing, and distribution of medical cables, leadwires, and neuromonitoring connections, aimed at improving patient monitoring solutions. Their core offerings include precise leadwires for cardiac monitoring, electrodes for brain monitoring, and supplies for muscle and nerve tests, catering to healthcare providers in cardiology, neurology, and sleep diagnostics across North America, Europe, and Asia.LifeSync generates revenue through direct sales of its medical cables and connections to healthcare providers and institutions, along with contract manufacturing partnerships. The company operates primarily on a B2B basis, receiving bulk orders from hospital systems and medical device manufacturers. LifeSync's pricing structure varies based on contract specifics and order volume, focusing on delivering quality products that enhance patient care and operational efficiency.Following the Series A financing round in January 2007, GMP Companies, Inc. aims to utilize the raised USD 17.2 mn to develop new medical products and expand into additional markets. Specific plans include targeting growth in regions such as Europe and Asia by 2025, with upcoming product launches planned to enhance their existing medical cable solutions.

## Funding rounds

- Series A, Jan 8, 2007, $17M — BVM Capital, MPM BioImpact, Janus Henderson Investors, Sterling Capital Funds

## Investors

- BVM Capital (https://capitalatlas.ai/funds/bvm-capital) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- Janus Henderson Investors — Series A
- Sterling Capital Funds — Series A